aap Implantate (0N5A) Price & Analysis

0 Followers

0N5A Stock Chart & Stats

€1.54

€0.07(4.58%)

At close: Jan 08 4:00 PM EST

€1.54

€0.07(4.58%)

Day’s Range― - ―

52-Week Range€1.35 - €2.34

Previous CloseN/A

Volume9.00

Average Volume (3M)3.00

Market Cap

€22.81M

Enterprise Value€28.81M

Total Cash (Recent Filing)€286.00K

Total Debt (Recent Filing)€3.97M

Price to Earnings (P/E)―

Beta0.21

Next Earnings

Aug 18, 2027

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.20

Shares Outstanding14,716,976

10 Day Avg. Volume0

30 Day Avg. Volume3

Financial Highlights & Ratios

PEG Ratio0.15

Price to Book (P/B)2.27

Price to Sales (P/S)1.58

P/FCF Ratio-9.15

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Strong Gross MarginAn approximately 82% gross margin indicates strong product-level economics in the orthopedic implant business. This provides a meaningful base for covering operating costs and funding commercial activity, while also leaving potential for improved earnings if the company can achieve better cost discipline and scale.

Manageable LeverageLow debt relative to equity limits balance-sheet pressure and reduces dependence on borrowing to sustain operations. Positive, sizable equity provides a cushion against continuing losses and preserves greater financial flexibility for restructuring, investment, or controlled growth over the next several quarters.

Specialized Orthopedic PositioningA focused portfolio of orthopedic implants and related surgical solutions gives the company a defined position in a specialized medical-technology market. Procedure-linked implants and supporting instruments can support recurring clinical demand when products remain relevant to surgeons and hospitals.

Bears Say

Persistent UnprofitabilityPersistent net losses show that strong gross profitability has not yet translated into a self-sustaining earnings model. Continued operating losses can consume equity, restrict investment capacity, and leave the company dependent on future operational improvement or external funding to support its strategy.

Ongoing Cash BurnNegative operating and free cash flow indicate that the core business is not currently funding itself. Continued cash consumption reduces financial resilience, may require additional financing or cost reductions, and limits the company’s ability to invest in products and market expansion without outside support.

Revenue Momentum WeakeningThe TTM revenue decline suggests weakening commercial momentum after a relatively stable revenue base. Lower sales can reduce operating leverage and make it harder to absorb fixed costs, increasing the challenge of converting the company’s high gross margin into sustainable profitability.

0N5A FAQ

What was aap Implantate AG’s price range in the past 12 months?

aap Implantate AG lowest share price was €1.35 and its highest was €2.34 in the past 12 months.

What is aap Implantate AG’s market cap?

aap Implantate AG’s market cap is €22.81M.

When is aap Implantate AG’s upcoming earnings report date?

aap Implantate AG’s upcoming earnings report date is Aug 18, 2027 which is in 310 days.

How were aap Implantate AG’s earnings last quarter?

aap Implantate AG released its earnings results on Aug 17, 2026. The company reported -€0.078 earnings per share for the quarter.

Is aap Implantate AG overvalued?

According to Wall Street analysts aap Implantate AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does aap Implantate AG pay dividends?

aap Implantate AG does not currently pay dividends.

What is aap Implantate AG’s EPS estimate?

aap Implantate AG’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does aap Implantate AG have?

aap Implantate AG has 14,716,976 shares outstanding.

What happened to aap Implantate AG’s price movement after its last earnings report?

aap Implantate AG reported an EPS of -€0.078 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of aap Implantate AG?

Currently, no hedge funds are holding shares in GB:0N5A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

aap Implantate Stock Smart Score

Neutral

Technicals

Fundamentals

Return on Equity

-32.36%

Trailing 12-Months

Asset Growth

15.18%

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

aap Implantate AG

Operating as a medical technology firm, aap Implantate AG specializes in the development, manufacturing, and commercialization of orthopedic trauma devices. The company's market presence spans Germany, the United States, and various international regions. Its primary offerings feature LOQTEQ, an advanced anatomical plating system crucial for fracture treatment, in addition to a diverse selection of cannulated screws, conventional plates, and standard screws. Products are distributed under the 'aap' brand, reaching customers directly, including hospitals, purchasing syndicates, and hospital groups, as well as indirectly via its network of distributors. aap Implantate AG was founded in 1990 and maintains its corporate headquarters in Berlin, Germany.